Shanghai Kehua Bio-Engineering specializes in advanced diagnostic technologies, particularly in the fields of clinical chemistry and immunology. The company offers a range of products, including Clinical Chemistry, CLIA, ELISA, and Colloidal Gold (POCT) tests. Their signature product line, KHB Polaris, encompasses both immunoassay and clinical chemistry solutions, showcasing their extensive manufacturing experience and technological development. Notably, their HIV colloidal gold test kit and enzyme immunoassay test kit have achieved high quality ratings from China's CDC, reflecting the reliability and effectiveness of their diagnostic tools.

In addition to their diagnostic kits, Shanghai Kehua Bio-Engineering has made significant strides in renal disease management, addressing the needs of the approximately 120 million adults in China affected by chronic renal disease. They provide an integrated solution for managing this condition, which highlights their commitment to improving healthcare outcomes. Furthermore, the company has developed an automated comprehensive solution for nucleic acid blood screening, utilizing advanced extraction and purification technologies from internationally recognized brands, thereby enhancing the efficiency and accuracy of their diagnostic processes.

China

Established in 1981, Shanghai Kehua Bio-engineering Co., Ltd (KHB) is one of the largest developers, manufacturers and marketers of in vitro diagnostic products in China. In July 2004, we became the first listed company in Shen Zhen Stock Exchange focused on the IVD business. We offer a broad range of products covering three primary business segments: Diagnostic Reagents, Diagnostic Laboratory Instruments, and Evacuated Receptacles.

Shanghai Kehua Bio-Engineering

Company Details